NIOSH Publication No. 2005-151:

NIOSH Pocket Guide to Chemical Hazards

September 2005

Nickel carbonyl

CAS
13463-39-3

Ni(CO)4

RTECS
QR6300000
Synonyms & Trade Names

Nickel tetracarbonyl, Tetracarbonyl nickel
DOT ID & Guide
1259 / 131

Exposure
Limits

NIOSH REL: Ca TWA 0.001 ppm (0.007 mg/m3) See Appendix A
OSHA PEL: TWA 0.001 ppm (0.007 mg/m3)
IDLH
Ca [2 ppm] See: 13463393
Conversion
1 ppm = 6.98 mg/m3
Physical Description
Colorless to yellow liquid with a musty odor. [Note: A gas above 110°F.]
MW: 170.7
BP: 110°F
FRZ: -13°F
Sol: 0.05%
VP: 315 mmHg
IP: 8.28 eV

Sp.Gr(63°F): 1.32
Fl.P: <-4°F
UEL: ?
LEL: 2%

Class IB Flammable Liquid: Fl.P. below 73F and BP at or above 100F.
Incompatibilities & Reactivities

Nitric acid, bromine, chlorine & other oxidizers; flammable materials
Measurement Methods
NIOSH 6007
See: NMAM or OSHA Methods
Personal Protection & Sanitation
(See protection)
Skin: Prevent skin contact
Eyes: Prevent eye contact
Wash skin: When contaminated
Remove: When wet (flammable)
Change: No recommendation
Provide: Eyewash, Quick drench
First Aid
(See procedures)
Eye: Irrigate immediately
Skin: Soap wash immediately
Breathing: Respiratory support
Swallow: Medical attention immediately
Respirator Recommendations
NIOSH
At concentrations above the NIOSH REL, or where there is no REL, at any detectable concentration:
(APF = 10,000) Any self-contained breathing apparatus that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode
(APF = 10,000) Any supplied-air respirator that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode in combination with an auxiliary self-contained positive-pressure breathing apparatus
Escape:
(APF = 50) Any air-purifying, full-facepiece respirator (gas mask) with a chin-style, front- or back-mounted canister providing protection against the compound of concern/Any appropriate escape-type, self-contained breathing apparatus
Important additional information about respirator selection
Exposure Routes
inhalation, ingestion, skin absorption, skin and/or eye contact
Symptoms
Headache, dizziness; nausea, vomiting, epigastric pain; substernal pain; cough, hyperpnea; cyanosis; lassitude (weakness, exhaustion); leukocytosis (increased blood leukocytes), pneumonitis; delirium, convulsions; [potential occupational carcinogen]; in animals: reproductive, teratogenic effects
Target Organs
Lungs, paranasal sinus, central nervous system, reproductive system

Cancer Site
[lung & nasal cancer]
See also: INTRODUCTION   See ICSC CARD: 0064   See MEDICAL TESTS: 0155